What is Infliximab?

Category: Prescription Drugs

Most popular types: Remicade Infimab Revellex

false

Infliximab is a monoclonal antibody used in the treatment of a number of autoimmune conditions, including: Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Crohn's disease 161 71
Rheumatoid arthritis 95 49
Ulcerative colitis 42 26
Psoriatic arthritis 39 21
Ankylosing spondylitis 34 16
Psoriasis 13 6

Show all 35 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
30
Moderate
39
Mild
47
None
68

Commonly reported side effects and conditions associated with Infliximab

Side effect Patients
Fatigue 19
Nausea 12
Headaches 10
Joint pain 7
Muscle and joint pain 7
Allergic reaction 4

Show all 108 reported side effects

Dosages

Based on patients currently taking Infliximab

Dosage Patients
100 mg every 8 weeks 6
100 mg every 6 weeks 5
400 mg every 8 weeks 3
100 mg monthly 2
700 mg every 6 weeks 2
1 mg every 8 weeks 1
1 other monthly 1
10 mg every 8 weeks 1
10 mg monthly 1
100 mg every 12 weeks 1

See all 25 dosages

Why patients stopped taking Infliximab

Multiple reasons could be selected

Reason Patients
Did not seem to work 73
Side effects too severe 59
Other 40
Doctor's advice 38
Expense 17
Change in health plan coverage 9
Course of treatment ended 5
Personal research 1
See all 175 patients who've stopped taking Infliximab

Duration

Currently taking Infliximab

Duration Patients
6 months - 1 year 5
1 - 2 years 5
2 - 5 years 10
5 - 10 years 10
10 years or more 12

Stopped taking Infliximab

Duration Patients
Less than 1 month 31
1 - 6 months 32
6 months - 1 year 32
1 - 2 years 29
2 - 5 years 36
5 - 10 years 13
10 years or more 4
Adherence
Adherence Evaluations
Always 161
Usually 10
Sometimes 5
Never taken as prescribed 8
Burden
Burden Evaluations
Very hard to take 14
Somewhat hard to take 63
A little hard to take 56
Not at all hard to take 51
Cost per month
Cost per month Evaluations
$200+ 28
$100-199 10
$50-99 6
$25-49 6
< $25 44
Not specified 90

What people switch to and from

Patients started taking Infliximab after stopping:

Treatment Patients
Adalimumab (Humira) 17
Mesalamine (Pentasa) 12
Etanercept (Enbrel SureClick) 10
Prednisone (Deltasone) 6
Sulfasalazine (Salazopyrin) 5

Show all 25 treatments patients report switching from

Patients stopped taking Infliximab and switched to:

Treatment Patients
Adalimumab (Humira) 20
Abatacept (Orencia) 7
Tocilizumab (Actemra) 3
Azathioprine (Imuran) 2
Budesonide (Pulmicort) 2

Show all 20 treatments patients report switching to

Last updated:

9 patient evaluations for Infliximab

Mar 22, 2017 (Started Mar 03, 2017)

  • Effectiveness
    Slight (for psoriatic arthritis)
  • Effectiveness
    Slight (for psoriasis worsened)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 6 mg Every 8 Weeks

  • 0 helpful marks

Jul 21, 2016 (Started Dec 12, 2015)

  • Effectiveness
    Major (for rheumatoid arthritis)
  • Effectiveness
    Moderate (for Crohn's disease)
  • Side effects
    Moderate (rash or skin problems, dry skin, dry throat)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg Every 8 Weeks
Advice & Tips: It takes commitment and time to work. My infusions are done at the GI clinic while some are outpatient at hospital. They take 3-4 hours and usually am extremely tired and groggy for couple of days.
Cost: $200+ monthly

  • 1 helpful mark

Jun 25, 2013 (Started Jul 01, 2005)

  • Effectiveness
    Major (for Crohn's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 750 mg Every 6 Weeks

  • 0 helpful marks
Last updated:
Showing 3 of 9 patient evaluations for Infliximab